T1	intervention 14 65	gonadotropin-releasing hormone analogue triptorelin
T2	condition 87 123	chemotherapy-induced early menopause
T3	eligibility 590 671	young patients with breast cancer undergoing adjuvant or neoadjuvant chemotherapy
T4	location 907 912	Italy
T5	No-of-participants 926 929	281
T6	duration 939 976	between October 2003 and January 2008
T7	eligibility 996 1115	premenopausal women with stage I through III breast cancer who were candidates for adjuvant or neoadjuvant chemotherapy
T9	control 1182 1200	chemotherapy alone
T10	outcome-Measure 1789 1817	Incidence of early menopause
T11	control-participants 2030 2033	133
T12	intervention-participants 2084 2087	148
T8	outcome 2245 2268	rate of early menopause
T13	control-value 2273 2278	25.9%
T14	intervention-value 2315 2319	8.9%
T15	outcome 2466 2499	treatment-related early menopause
